From MarketWatch.com….
23andMe, a consumer genetics company, is going public via a merger with Richard Branson’s special purpose acquisition corporation (SPAC) VG Acquisition Corp. VGAC, 10.17%, in a deal with an enterprise value of about $3.5 billion, the companies said Thursday.
